NEXT Financial Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

NEXT Financial Holdings’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$134K	Buy	+730	New	+$135K	0.03%	461

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

NEXT Financial Holdings's VRTX Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2019: 730 shares worth $134K. The stake represents 0.03% of the portfolio and ranks #461 among its holdings.

736 funds tracked by Wall St. Rank hold VRTX as of Q1 2019.

NEXT Financial Holdings held 730 shares of Vertex Pharmaceuticals worth $134K as of Q1 2019.
Vertex Pharmaceuticals was a new NEXT Financial Holdings position in Q1 2019.
Vertex Pharmaceuticals made up 0.03% of NEXT Financial Holdings's portfolio in Q1 2019, its #461 holding.
736 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.